KR102651945B1 - Hbed-비스포스포네이트, 이의 방사성금속 접합체 및 이의 진단치료제로서의 용도 - Google Patents

Hbed-비스포스포네이트, 이의 방사성금속 접합체 및 이의 진단치료제로서의 용도 Download PDF

Info

Publication number
KR102651945B1
KR102651945B1 KR1020187002872A KR20187002872A KR102651945B1 KR 102651945 B1 KR102651945 B1 KR 102651945B1 KR 1020187002872 A KR1020187002872 A KR 1020187002872A KR 20187002872 A KR20187002872 A KR 20187002872A KR 102651945 B1 KR102651945 B1 KR 102651945B1
Authority
KR
South Korea
Prior art keywords
group
complex
compound
hydrogen
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187002872A
Other languages
English (en)
Korean (ko)
Other versions
KR20180026736A (ko
Inventor
한크 에프. 쿵
쩌후이 우
석 례 최
칼 플뢰슬
지하오 자
Original Assignee
파이브 일레븐 파마 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파이브 일레븐 파마 인크. filed Critical 파이브 일레븐 파마 인크.
Publication of KR20180026736A publication Critical patent/KR20180026736A/ko
Application granted granted Critical
Publication of KR102651945B1 publication Critical patent/KR102651945B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiology & Medical Imaging (AREA)
  • Steroid Compounds (AREA)
KR1020187002872A 2015-07-07 2016-07-06 Hbed-비스포스포네이트, 이의 방사성금속 접합체 및 이의 진단치료제로서의 용도 Active KR102651945B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562189652P 2015-07-07 2015-07-07
US62/189,652 2015-07-07
US201662320296P 2016-04-08 2016-04-08
US62/320,296 2016-04-08
PCT/US2016/041040 WO2017007790A1 (en) 2015-07-07 2016-07-06 Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents

Publications (2)

Publication Number Publication Date
KR20180026736A KR20180026736A (ko) 2018-03-13
KR102651945B1 true KR102651945B1 (ko) 2024-03-26

Family

ID=57685907

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187002872A Active KR102651945B1 (ko) 2015-07-07 2016-07-06 Hbed-비스포스포네이트, 이의 방사성금속 접합체 및 이의 진단치료제로서의 용도

Country Status (11)

Country Link
US (1) US10253052B2 (cg-RX-API-DMAC7.html)
EP (1) EP3319643B1 (cg-RX-API-DMAC7.html)
JP (1) JP6792875B2 (cg-RX-API-DMAC7.html)
KR (1) KR102651945B1 (cg-RX-API-DMAC7.html)
CN (1) CN107847618B (cg-RX-API-DMAC7.html)
AU (1) AU2016289474C1 (cg-RX-API-DMAC7.html)
DK (1) DK3319643T3 (cg-RX-API-DMAC7.html)
EA (1) EA201890221A1 (cg-RX-API-DMAC7.html)
IL (1) IL256726A (cg-RX-API-DMAC7.html)
MX (1) MX377208B (cg-RX-API-DMAC7.html)
WO (1) WO2017007790A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3319643T3 (da) 2015-07-07 2020-06-15 Five Eleven Pharma Inc HBED-bisphosphonater og radiometalkonjugater deraf, anvendelige som theranostiske midler
WO2018160544A1 (en) * 2017-03-02 2018-09-07 Five Eleven Pharma Inc. Radiopharmaceutical labeling device
WO2020028825A1 (en) * 2018-08-03 2020-02-06 Board Of Regents, The University Of Texas System Method for extraction and purification of 68ga
CN109438517B (zh) * 2018-12-27 2021-01-08 北京久杰净化工程技术有限公司 一种与羰基金属核心配位的双功能连接剂的配合物及其制备方法
MX2021013055A (es) * 2019-04-26 2021-12-10 Five Eleven Pharma Inc Inhibidores de antigenos de membrana especificos de prostata (psma) como agentes diagnosticos y terapeuticos con radionuclidos.
US20230001027A1 (en) * 2019-10-01 2023-01-05 City Of Hope Metal chelating agents and methods of using the same
DE102021101216A1 (de) * 2021-01-21 2022-07-21 Johannes Gutenberg-Universität Mainz, Körperschaft des öffentlichen Rechts Markierungsvorläufer und Radiotracer zur nuklearmedizinischen Diagnose und Therapie von Prostatakrebs induzierten Knochenmetastasen
DE102022105175A1 (de) * 2022-03-04 2023-09-07 Atoms for Cure GmbH Markierungsvorläufer und Radiotracer mit drei oder mehr Targeting-Vektoren für die nuklearmedizinische Theranostik
CN119060094B (zh) * 2024-08-26 2025-09-05 广州医科大学附属第一医院(广州呼吸中心) 一种靶向成纤维细胞激活蛋白的抑制剂类放射性探针及其制备方法和应用
CN119060093B (zh) * 2024-08-26 2025-09-05 广州医科大学附属第一医院(广州呼吸中心) 一种靶向成纤维细胞激活蛋白的抑制剂类放射性探针及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005507001A (ja) * 2001-10-22 2005-03-10 ダウ グローバル テクノロジーズ インコーポレイティド 初期癌の治療用放射線医薬薬剤
WO2004089925A1 (en) * 2003-04-03 2004-10-21 Semafore Pharmaceuticals, Inc. Pi-3 kinase inhibitor prodrugs
US7161000B2 (en) * 2003-05-30 2007-01-09 Sumitomo Chemical Company, Limited Method for producing phenol condensate
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
WO2009002529A2 (en) * 2007-06-26 2008-12-31 The Johns Hopkins University Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents
EP2468760B1 (en) * 2009-08-20 2014-10-01 Fujifilm RI Pharma Co., Ltd. Bisphosphonic acid derivative and compound thereof labeled with radioactive metal nuclide
US9212335B2 (en) * 2011-04-13 2015-12-15 Firmenich Sa Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones
ITMI20121156A1 (it) 2012-06-29 2013-12-30 Consiglio Nazionale Ricerche Metodo di elaborazione di immagini di tomografia a coerenza ottica
EP2862857A1 (en) * 2013-10-18 2015-04-22 Deutsches Krebsforschungszentrum Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
DK3319643T3 (da) 2015-07-07 2020-06-15 Five Eleven Pharma Inc HBED-bisphosphonater og radiometalkonjugater deraf, anvendelige som theranostiske midler

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Nuclear Medicine and Biology, 39, 993-999(2012.)

Also Published As

Publication number Publication date
JP6792875B2 (ja) 2020-12-02
AU2016289474A1 (en) 2018-02-01
WO2017007790A9 (en) 2018-01-04
CN107847618A (zh) 2018-03-27
US10253052B2 (en) 2019-04-09
IL256726A (en) 2018-03-29
DK3319643T3 (da) 2020-06-15
CA2991498A1 (en) 2017-01-12
EA201890221A1 (ru) 2018-06-29
AU2016289474B2 (en) 2020-12-24
KR20180026736A (ko) 2018-03-13
AU2016289474C1 (en) 2021-04-08
US20170022224A1 (en) 2017-01-26
WO2017007790A1 (en) 2017-01-12
CN107847618B (zh) 2021-07-16
EP3319643B1 (en) 2020-04-22
MX2018000239A (es) 2018-05-23
EP3319643A1 (en) 2018-05-16
JP2018524352A (ja) 2018-08-30
EP3319643A4 (en) 2019-04-10
MX377208B (es) 2025-03-07
HK1254864A1 (en) 2019-07-26

Similar Documents

Publication Publication Date Title
KR102870722B1 (ko) 진단제 및 방사성핵종 치료제로서의 전립선-특이적 막 항원 (psma) 억제제
JP6792875B2 (ja) Hbed−ビスホスホネート、その放射性金属コンジュゲート、およびセラノスティック剤としてのそれらの使用
JP6850027B2 (ja) イメージング及び治療のための尿素系前立腺特異的膜抗原(psma)阻害剤
HU219485B (hu) Eljárás 1,4,7,10-tetraaza-ciklododekán-származékok, ezek komplexei, valamint antitestekkel képzett konjugátumai, és ilyeneket tartalmazó gyógyszerkészítmények előállítására és a komplexeket, illetve konjugátumokat tartalmazó diagnosztikai készítmények
CN107106711A (zh) 用于诊断和治疗骨病的共轭二膦酸盐
HUT70447A (en) Polyazamacrocyclic compounds for producing complexes of metal ions
KR20240158290A (ko) 핵의학에서 사용되는 테라노스틱스를 위한 3개 이상의 표적화 벡터를 갖는 전구체 표지자 및 방사성 추적자
JP2005523235A (ja) 新規のキレート化剤およびその接合体、該キレート化剤およびその接合体の診断剤および治療剤としての合成および使用
CA2991498C (en) Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents
HK1254864B (en) Hbed-bisphosphonates and radiometal conjugates thereof, useful as theranostic agents
HK1248585B (en) Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents
HK1248585A1 (en) Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents
KR0153501B1 (ko) 오르토 결합 작용기를 갖는 킬란트 및 그의 착물
HK1255215B (en) Urea-based prostate specific membrane antigen (psma) inhibitors for imaging and therapy

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180130

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210706

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20231005

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20231222

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240322

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240322

End annual number: 3

Start annual number: 1

PG1601 Publication of registration